Could a device extend life for advanced breast cancer patients?
Disease control
Not yet recruiting
This study tests a device called TheraBionic P1 in 82 people with advanced or metastatic HR-positive, HER2-negative breast cancer whose cancer has progressed after standard hormone therapy. The goal is to see if using the device can help patients live longer without their cancer …
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC